Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection

Cell Reports(2021)10.1016/j.celrep.2021.109056Source: DataRank Database

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (40)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Donal McHugh ORCID,Lisa Rieble ORCID,Catherine S. Forconi ORCID,John Michael Ong’echa ORCID,Peter O. Oluoch ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: FK-18-026

National Institutes of Health

Grant: R01 CA189806

Swiss National Science Foundation

Grant: CRSII5_180323

Swiss National Science Foundation

Grant: 310030B_182827

Schweizerische Akademie der Medizinischen Wissenschaften

Grant: 323630_19938

Schweizerische Akademie der Medizinischen Wissenschaften

Grant: 323530_145247

National Institutes of Health

Grant: 5R01CA189806-08

Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma

Swiss National Science Foundation

Grant: 182827

Excellence Grant - Role of autophagy proteins in endocytosis and exocytosis

Swiss National Science Foundation

Grant: 180323

Novel virucidal drugs: From basic to in vivo studies

goldLicense: CC BY NC ND

publisherhttp://www.cell.com/article/S2211124721003727/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721003727?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721003727?httpAccept=text/plain

https://escholarship.umassmed.edu/oapubs/4719

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10285879/pdf/nihms-1899420.pdf

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

humanized mouse modelEpstein-Barr Virus InfectionsSupplementary InformationQH301-705.5General Biochemistry,Genetics and Molecular Biology610Infectious Disease610 Medicine & healthImmunopathologyKSHVR Medicine10263 Institute of Experimental ImmunologyKaposi sarcoma-associated herpesvirus333ArticleMiceCD56-negative NK cellsHemic and Lymphatic Diseases1300 General Biochemistry, Genetics and Molecular BiologyEBV616Epstein-Barr virusAnimalsHumansBiology (General)610 Medicine & healthnatural killer cellsRCell DifferentiationKiller Cells, NaturalImmunology of Infectious DiseaseImmune System DiseasesVirus DiseasesVirusesHerpesvirus 8, Human570 Life sciences; biologyOther

Sustainable Development Goals

SDG 3: 3. Good health